Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
The Coca-Cola Company ( KO - Analyst Report ) recently completed its acquisition of the beverage segment of Aujan Industries. The acquisition was first announced in December 2011.
According to the terms of the contract, The Coca Cola Company will own the 50% of the Aujan segment that operates 49% of its bottling and distribution business and owns the Aujan owned brands, thus allowing the company to expand its business in the Middle East. The Middle East appears to be a very promising market, as the company achieved double-digit volume growth from the Middle East business in the second quarter of 2012. The acquisition is also expected to help The Coca-Cola Company expand its portfolio in the juice segment.
The company is still largely dependent on its carbonated beverages. However, with increasing consumer health awareness, Coca-Cola is slowly expanding the portfolio of non-carbonated drinks. Coca-Cola commands a leading position in the juices or still beverages category, with its flagship brands Minute Maid, Simply and POWERade.
On the other hand, as one of the leading beverage companies in the Middle East, Aujan Industries will benefit from the global exposure and expertise of The Coca-Cola Company and will be able to build its leading brands and business.
We are encouraged by the company’s global reach, strong brand power, expanding presence outside the U.S. and its solid cash position. Moreover, the company’s strategy of growing through acquisitions and its productivity initiatives are expected to result in significant cost savings and improved productivity in the near future. However, soft economic conditions and a tough currency environment ahead concern us.
Currently, we have a Neutral recommendation on The Coca-Cola Company over the long term. The Coca-Cola Company carries a Zacks #3 Rank in the near term (Hold rating).
Read the full Analyst Report on KO